Biotricity, Inc. BTCY · Stock Open Biotricity, Inc. in new tab
Biotricity, Inc. Analysis (BTCY)
Is Biotricity, Inc. a good investment? Biotricity, Inc. (BTCY) is currently trading at 0.0575 USD.
Earnings Schedule: Biotricity, Inc. is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -0.43.
Investor FAQ
Does Biotricity, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Biotricity, Inc.?
Biotricity, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -0.13.
Company Profile
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.
Community Discussion